|
Match
|
Document |
Document Title |
|
|
US20090269400 |
Nanoparticulate and Controlled Release Compositions Comprising a Cephalosporin
The present invention is directed to compositions comprising a nanoparticulate antibiotic having improved bioavailability. Preferably, the antibiotic comprises nanoparticulate cephalosporin...
|
|
|
US20090263466 |
HERBAL COMPOSITION FOR TREATMENT OF HYPERLIPIDEMIA AND THE INHIBITION OF MYOCARDIAL INFARCTION
A pharmaceutical or medicinal herbal composition and method of making the composition comprised of a mixture of the following herbal ingredients: Glycine max, Plumbago zeylanica, Terminalia...
|
|
|
US20090232886 |
ORAL DOSAGE COMBINATION PHARMACEUTICAL PACKAGING
Pharmaceutical fixed dose combination products are formed by merging a fixed dose of a first pharmaceutical formulation from primary module, with a fixed dose of a second pharmaceutical formulation...
|
|
|
US20090226513 |
Na/K-ATpase Ligand
This process relates to a pharmaceutical composition of an Na-K-ATPase ligand which will stimulate Na/K-ATPase signaling in a pharmaceutically acceptable vehicle. In one embodiment, the composition...
|
|
|
US20090226512 |
Methods and Compositions for Oral Delivery of FTS
Disclosed are oral dosage forms containing a Ras antagonist including FTS and structural analogs thereof, and at least one pharmaceutically acceptable excipient other than a cyclodextrin, and...
|
|
|
US20090220592 |
PREPARATION FOR THE TREATMENT OF TINNITUS
The invention relates to the use of blueberry extract for the preparation of a therapeutic composition for oral administration for the treatment and prevention of tinnitus.
|
|
|
US20090220591 |
Pharmaceutical Compositions Comprising Non-Steroidal Antiinflammatory Drug, Antipyretic-Analgesic Drug and Proton Pump Inhibotor
The present invention relates to pharmaceutical compositions in the form of fixed combination comprising non-steroidal anti-inflammatory drug or its single enantiomers or salts thereof,...
|
|
|
US20090214641 |
Sweetened Capsules for Administration
In an aspect of the present invention, a sweetened gelatin capsule comprises a dose and a gelatin capsule encapsulating the dose. The gelatin capsule comprises a gelatin substance, a gelatin...
|
|
|
US20090208569 |
Homogeneous, Thermoreversible Alginate Films and Soft Capsules Made Therefrom
The present invention is directed to a homogeneous, thermoreversible gel film comprising a film forming amount of a water soluble, thermoreversible alginate, and optionally at least one of a...
|
|
|
US20090196920 |
PHARMACEUTICAL COMPOSITION COMPRISING MICROCAPSULES OF STATINS SUSPENDED IN ALKYL ESTERS OF POLYUNSATURATED FATTY ACIDS (PUFA)
The invention relates to a pharmaceutical composition comprising a suspension consisting of an oil with a high concentration of alkyl esters of polyunsaturated fatty acids (PUFA) and to...
|
|
|
US20090181080 |
Oral cannabinnoid liquid formulations and methods of treatment
A room temperature stable aqueous cannabinoid formulation is disclosed. In preferred embodiments, the cannabinoid formulation comprises dronabinol in a mixture of buffer solution, and organic...
|
|
|
US20090175934 |
Extended Release Pharmaceutical Formulation of Venlafaxine and Method of Manufacturing the Same
Disclosed herein is an extended release pharmaceutical formulation suitable for once daily administration, comprising a highly water soluble core consisting essentially of about 30 to about 40% by...
|
|
|
US20090175933 |
PREPARATION FOR THE TREATMENT OF DIARRHOEA
A preparation for the treatment of diarrhoea comprising a bulking agent and an anti-diarrhoeal agent wherein the anti-diarrhoeal agent is provided in the form of an anti-motility agent.
|
|
|
US20090155356 |
THIXOTROPIC OIL BASED VEHICLE FOR PHARMACEUTICAL COMPOSITIONS
The present invention relates to a novel thixotropic oily vehicle comprising between about 0.2% to about 5% (w/w) of a colloidal silica and between about 0.2% to about 5% (w/w) of a hydrophilic...
|
|
|
US20090148516 |
TREATED FEED SUPPLEMENT CAPSULE FOR RUMINANTS
A formaldehyde-treated protein capsule for protecting any encapsulated substance from chemical modification in the rumen is generally disclosed. Also, processes for making and using the...
|
|
|
US20090130203 |
EXTRACTS OF CHENOPODIUM AMBROSIOIDES L., THE COMPOSITIONS COMPRISING SAID EXTRACTS, THE PREPARING PROCESS AND APPLICATION THEREOF
The present invention relates to plant extracts, specifically, the extracts of Chinese medicine Chenopodium ambrosioides L. and the composition comprising thereof. The extracts of Chinese medicine...
|
|
|
US20090130202 |
Pharmaceutical Compositions
Sustained release pharmaceutical compositions contain a drug; microcrystalline cellulose; a diluent (such as starch); a glidant (such as talc); and one or more of ethylcellulose, stearic acid and a...
|
|
|
US20090130200 |
GRANULES FOR CONTROLLED RELEASE OF TAMSULOSIN
Granules for controlled release of Tamsulosin, the granules including Tamsulosin and a carrier matrix. The carrier matrix includes a) 2 to 25% by weight of an alginate and b) 30 to 70% by weight of...
|
|
|
US20090123386 |
Abuse Resistant Capsules
Hard shell capsules filled with a pharmaceutical medicament and at least one modifier, selected to prevent abuse of the medicament are described. The modifier may have a high melting point, and...
|
|
|
US20090110724 |
COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN
The present invention relates to compositions and methods for treatment of various forms of pain. Specifically, the method involves administering to a patient a composition comprising butalbital,...
|
|
|
US20090092667 |
Method for Reducing Amyloid Deposition, Amyloid Neurotoxicity, and Microgliosis with (-)-Nilvadipine Enantiomer
The present invention provides methods for reducing Aβ deposition, Aβ neurotoxicity and microgliosis in an animal or human afflicted with a cerebral amyloidogenic disease, such as Alzheimer's...
|
|
|
US20090087478 |
Orally Deliverable and Anti-Toxin Antibodies and Methods for Making and Using Them
The invention provides antibodies with superior therapeutic efficacy and related methods of engineering such antibodies to increase their stability and resistance to proteases, e.g., in the...
|
|
|
US20090081287 |
Pharmaceutical Composition Containing Gelling Agent
Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically...
|
|
|
US20090074857 |
Glycerophospholipids for the improvement of cognitive functions
Disclosed herein are alternative, enhanced, and cheaper methods of improving cognitive functions in a subject using a lipid composition conjugated with omega-3 and omega-6 fatty acids, with...
|
|
|
US20090074856 |
CRYSTALLINE PYRIMIDINE NUCLEOSIDE DERIVATIVE SUSPENSIONS IN CAPSULES
The present invention relates to a pharmaceutical formulation which comprises (i) a capsule, and (ii) a core comprising crystalline 2′-cyano-2′-deoxy-N 4 -palmitoyl- 1...
|
|
|
US20090074855 |
ENTERIC COASTINGS FOR ORALLY INGESTIBLE COMPOSITIONS
A suspendible enteric coating composition for encasing orally ingestible articles wherein the enteric coating composition comprises a pH-dependent polymer selected from a group containing alginates...
|
|
|
US20090060975 |
CONTAINMENT SYSTEM FOR DELIVERY OF BIOLOGICAL PRODUCTS AND METHOD OF SURGERY
Methods and systems for delivering biological products such as bone marrow aspirate (BMA) to different surgical sites during surgery (for example, arthroscopic surgery). The biological product is...
|
|
|
US20090053307 |
IMMEDIATE-RELEASE THERAPEUTIC SYSTEMS FOR IMPROVED ORAL ABSORPTION OF 7-[(E)]-T-BUTY-LOXYMINOMETHYL] CAMPTOTHECIN
A pharmaceutical composition comprising a camptothecin as active ingredient is herein described. In particular immediate-release therapeutic systems are described for the improved oral absorption...
|
|
|
US20090053306 |
Pharmaceutical Compositions of a 5-HT2A Serotonin Receptor Modulator Useful for the Treatment of Disorders Related Thereto
The present invention relates to certain pharmaceutical compositions of a 5-HT 2A serotonin receptor modulator and methods for preparing pharmaceutical composition related thereto. The...
|
|
|
US20090047342 |
Methods of Treating Infectious Diseases
The present invention provides methods of treating a human or other mammal infected with a parasitic microorganism by administering an effective amount in unit dosage form of a C 8 -C 16 -alpha,...
|
|
|
US20090035369 |
Composition and Methods for Treating and Preventing Age-Related Macular Degeneration
The present invention relates to methods and compositions effective in preventing, attenuating, inhibiting the progression of, and treating eye diseases, e.g., age-related macular degeneration...
|
|
|
US20090022788 |
DIETARY SUPPLEMENT FOR HEALING OR REGRESSING SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE, GASTRITIS AND ULCERS
The current invention presents a dietary supplement obtained from a mixture of melatonin, vitamins and aminoacids for healing or regressing symptoms of gastroesophageal reflux disease (such as...
|
|
|
US20090022787 |
PHARMACEUTICAL COMPOSITION COMPRISING 11-DEOXY- PROSTAGLANDIN COMPOUND AND METHOD FOR STABILIZING THE COMPOUND
Provided is a pharmaceutical composition comprising a 11-deoxy-prostaglandin compound represented by formula (I):
and a fatty acid ester. By mixing the compound of formula (I) and a fatty acid...
|
|
|
US20090017112 |
Compounds for Inhibiting Beta-Amyloid Production
Provided are compounds useful for treating diseases associated with a cerebral accumulation of Alzheimer's amyloid, such as Alzheimer's disease. Also provided are methods of treating or reducing...
|
|
|
US20090004262 |
Nanoparticulate formulations and methods for the making and use therof
The present invention is directed to size-stabilized drug nanoparticulate compositions and methods of preparation thereof.
|
|
|
US20080317844 |
Pharmaceutical Delivery Systems for Hydrophobic Drugs and Compositions Compositions Comprising Same
A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising...
|
|
|
US20080317843 |
NANOPARTICULATE FORMULATIONS OF MODAFINIL
The present invention is directed to compositions comprising a nanoparticulate modafinil compositions, or a salt(s), or an enantiomer(s), or a prodrug(s), or a polymorph(s) or derivative thereof,...
|
|
|
US20080317791 |
Kappa Carrageenan
Disclosed is a carrageenan composition comprising sodium, potassium, calcium and magnesium.
|
|
|
US20080311190 |
Thrombin-Free Biological Adhesive and Use Thereof as a Medicament
The invention relates to a thrombin-free, fibrinogen-based biological adhesive for therapeutic use, which comprises factor VIIa and a source of calcium ions. The invention also relates to the use...
|
|
|
US20080311189 |
Compositions Comprising Organometallic Molybdenum Compounds For Treating Cancer
The invention provides several molybdenum (II) complexes (see classes I and II, FIG. 1 ) as well as pharmaceutical compositions comprising these compounds, that are useful for treating cancer and...
|
|
|
US20080305163 |
BUTYLPHTHALIDE SOFT GEL CAPSULE AND ITS PREPARATION PROCEDURE
The present invention discloses a novel dosage form of butylphthalide soft capsule and its preparation procedure. Butylphthalide soft capsule is composed of a coating material and a drug-containing...
|
|
|
US20080305162 |
Incontinence Treatment Methods
The invention relates to the fields of pharmaceutical chemistry and pharmacological treatments. More specifically, the invention relates to compositions and methods for the treatment of...
|
|
|
US20080305161 |
INJECTABLE DEPOT FORMULATIONS AND METHODS FOR PROVIDING SUSTAINED RELEASE OF NANOPARTICLE COMPOSITIONS
Pharmaceutical formulations comprising: a compound selected from the group consisting of ziprasidone, having a maximum average particle size; a carrier; and preferably at least two surface...
|
|
|
US20080305160 |
Oral Medicament For The Modified Release Of At Least One Active Principle, In Multimicrocapsule Form
The field of the invention is that of oral medicaments or pharmaceutical compositions, in particular of the type including one or more active principles. The aim of the invention is to provide an...
|
|
|
US20080292693 |
COMPOSITION AND METHOD FOR TREATING DIGESTIVE SYSTEM DISORDERS
The present disclosure provides for a novel composition, with active ingredients comprising d-Limonene and Aloe mucilaginous polysaccharides (AMPs), for the treatment of a wide variety of digestive...
|
|
|
US20080286356 |
Pharmaceutical compositions containing terbinafin and use thereof
Pharmaceutical compositions for oral administration comprising terbinafine and a method for administering high dosages while minimizing effects associated with e.g. a high dosage load, e.g. coated...
|
|
|
US20080286355 |
Protease Inhibitors For the Treatment of Digestive Pathologies
The invention relates to compositions and methods for the treatment of intestinal pathologies. The invention also relates to compositions and methods which can be used to regulate the paracellular...
|
|
|
US20080279929 |
Nanoparticulate and Controlled Release Compositions Comprising Cefditoren
The present invention provides a composition comprising a cefditoren, or a salt, derivative, prodrug, or other form thereof, for example, cefditoren pivoxil, useful in the treatment and prevention...
|
|
|
US20080274175 |
Compositions Comprising Edible Oils and Vitamins and/or Minerals and Methods for Making the Compositions
The invention provides compositions for an administration to a mammal orally or in a suppository that include one or more edible oils (preferably including one or more omega-3 fatty acids), one or...
|
|
|
US20080268042 |
OMEGA 3 FATTY ACID FORMULATIONS
The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other...
|